Abstract

Post-COVID condition (PCC) and multiple sclerosis (MS) share some clinical and demographic features, including cognitive symptoms and fatigue. Some pathophysiological mechanisms well-known in MS, such as autoimmunity, neuroinflammation and myelin damage, have also been implicated in PCC. In this study, we aimed to compare the cognitive phenotypes of two large cohorts of patients with PCC and MS, and to evaluate the relationship between fatigue and cognitive performance. Cross-sectional study including 218 patients with PCC and 218 with MS matched by age, sex, and years of education. Patients were evaluated with a comprehensive neuropsychological protocol and were categorized according to the International Classification of Cognitive Disorders system. Fatigue and depression were also assessed. Cognitive profiles of PCC and MS largely overlapped, with a greater impairment in episodic memory in MS, but with small effect sizes. The most salient deficits in both disorders were in attention and processing speed. The severity of fatigue was greater in patients with PCC. Still, the correlations between fatigue severity and neuropsychological tests were more prominent in the case of MS. There were no differences in the severity of depression among groups. Our study found similar cognitive profiles in PCC and MS. Fatigue was more severe in PCC, but was more associated with cognitive performance in MS. Further comparative studies addressing the mechanisms related to cognitive dysfunction and fatigue may be of interest to advance the knowledge of these disorders and develop new therapies.

Details

Title
Cognitive profile in multiple sclerosis and post-COVID condition: a comparative study using a unified taxonomy
Author
Delgado-Alonso, Cristina 1 ; Delgado-Alvarez, Alfonso 1 ; Díez-Cirarda, María 1 ; Oliver-Mas, Silvia 1 ; Cuevas, Constanza 1 ; Montero-Escribano, Paloma 1 ; Ramos-Leví, Ana Maria 2 ; Gil-Moreno, María José 1 ; López-Carbonero, Juan Ignacio 1 ; Hermann, Bruce P. 3 ; Matias-Guiu, Jorge 1 ; Matias-Guiu, Jordi A. 1   VIAFID ORCID Logo 

 Instituto de Investigacion Sanitaria “San Carlos” (IdISSC), Department of Neurology, Hospital Clínico San Carlos, Madrid, Spain (GRID:grid.411068.a) (ISNI:0000 0001 0671 5785) 
 Instituto de Investigacion Sanitaria “San Carlos” (IdISSC), Department of Endocrinology, Hospital Clínico San Carlos, Madrid, Spain (GRID:grid.411068.a) (ISNI:0000 0001 0671 5785) 
 University of Wisconsin, Department of Neurology, School of Medicine and Public Health, Madison, USA (GRID:grid.14003.36) (ISNI:0000 0001 2167 3675) 
Pages
9806
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3048261813
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.